No Racial Differences Found in Access to Biologics: A Population-Based Study of Psoriasis Patients in the United States

August 2023 | Volume 22 | Issue 8 | 835 | Copyright © August 2023


Published online July 31, 2023

Rasika Reddy MDa, Sabrina Khan MDb, Danielle Yee MDb, Nicole Maynard MDb, Manan Mehta MDb, Caterina Zagona-Prizio MDc, Samiya Khan MDd, Vipawee Chat MDb, Kevin Wu MDb, April W. Armstrong MD MPHb

aUniversity of Texas Southwestern Medical Center, Dallas, TX
bKeck School of Medicine, University of Southern California, Los Angeles, CA
cUniversity of Colorado School of Medicine, Denver, CO
dLong School of Medicine, University of Texas at San Antonio, San Antonio, TX

REFERENCES

  1. Kaufman BP, Alexis AF. Psoriasis in skin of color: insights into the epidemiology, clinical presentation, genetics, quality-of-life impact, and treatment of psoriasis in non-White racial/ethnic groups. Am J Clin Dermatol. 2018;19(3):405-423.
  2. Yan D, Afifi L, Jeon C, et al. A cross-sectional study of the distribution of psoriasis subtypes in different ethno-racial groups. Dermatol Online J. 2018;24(7):13030/qt5z21q4k2.
  3. Florek AG, Wang CJ, Armstrong AW. Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review. Arch Dermatol Res. 2018;310(4):271-319.
  4. Kamangar F, Isip L, Bhutani T, et al. How psoriasis patients perceive, obtain, and use biologic agents: Survey from an academic medical center. J Dermatolog Treat. 2013;24(1):13-24.
  5. Kerr GS, Qaiyumi S, Richards J, et al. Psoriasis and psoriatic arthritis in African-American patients--the need to measure disease burden. Clin Rheumatol. 2015;34(10):1753-1759.
  6. Hodges WT, Bhat T, Raval NS, et al. Biologics utilization for psoriasis is lower in black compared with white patients. Br J Dermatol. 2021;185(1):207-209.
  7. Takeshita J, Gelfand JM, Li P, et al. Psoriasis in the US Medicare population: prevalence, treatment, and factors associated with biologic use. J Invest Dermatol. 2015;135(12):2955-2963.
  8. Bell MA, Whang KA, Thomas J, et al. Racial and ethnic disparities in access to emerging and frontline therapies in common dermatological conditions: a cross-sectional study. J Natl Med Assoc. 2020;112(6):650-653.
  9. Rehman R, Mateen Z, Osto M, Mehregan D. Ethnic distribution of populations in the highest and lowest dermatologist-dense areas: is there more to the story? Dermatol Online J. 2022;28(1):10.5070/D328157056
  10. Bray JK, Cline A, McMichael AJ, et al. Differences in healthcare barriers based on racial and/or ethnic background for patients with psoriasis. J Dermatolog Treat. 2021;32(6):590-594.
  11. Chat VS, Hekmatjah J, Sierro TJ, et al. Language proficiency and biologics access: a population study of psoriasis patients in the United States. J Dermatolog Treat. 2022;33(3):1413-1417.

AUTHOR CORRESPONDENCE

April W. Armstrong MD MPH armstrongpublication@gmail.com
Close Menu